What is the recommended initial dose of noradrenaline (norepinephrine) for an adult patient in septic shock?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 23, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Noradrenaline Dose in Septic Shock

Start norepinephrine as the first-line vasopressor as soon as hypotension persists after initial fluid resuscitation, targeting a mean arterial pressure (MAP) of 65 mmHg, with no specific initial dose mandated by guidelines—titrate to achieve the MAP target. 1

Initial Administration Protocol

Norepinephrine is the mandatory first-choice vasopressor in septic shock with a strong recommendation (Grade 1B). 1

Pre-Vasopressor Requirements

  • Administer a minimum of 30 mL/kg of crystalloids in the first 3 hours before or concurrent with vasopressor initiation 2, 3
  • Establish central venous access for safe norepinephrine administration 2, 4, 3
  • Place an arterial catheter as soon as practical for continuous blood pressure monitoring 1, 2

Dosing Strategy

Guidelines do not specify a fixed starting dose—instead, they mandate titration to achieve MAP ≥65 mmHg. 1 The typical starting range in clinical practice is 0.05-0.1 mcg/kg/min, though this is not explicitly stated in the Surviving Sepsis Campaign guidelines.

  • Target MAP of 65 mmHg in most patients 1, 2, 3
  • Consider higher MAP targets (70-85 mmHg) in patients with chronic hypertension 3
  • Titrate continuously based on hemodynamic response and tissue perfusion markers (lactate clearance, urine output ≥0.5 mL/kg/h, mental status) 2, 5

Timing Considerations

Do not delay norepinephrine while pursuing aggressive fluid resuscitation if severe, life-threatening hypotension is present. 2 Early norepinephrine administration (within 93 minutes of emergency room arrival) significantly increases shock control rates by 6 hours (76.1% vs 48.4%, P<0.001) and reduces complications including cardiogenic pulmonary edema and new-onset arrhythmias. 5

  • Consider immediate norepinephrine when diastolic blood pressure ≤40 mmHg or diastolic shock index (heart rate/diastolic BP) ≥3 6, 7
  • Early administration prevents prolonged severe hypotension, which strongly worsens outcomes 6, 7

Escalation for Refractory Hypotension

Second-Line Agent: Vasopressin

Add vasopressin at 0.03 units/minute (range 0.01-0.03 units/min) when norepinephrine alone fails to achieve target MAP, particularly when norepinephrine doses reach 0.25-0.50 mcg/kg/min. 1, 2, 8

  • Vasopressin should never be used as monotherapy—always add to norepinephrine 2, 4, 3
  • Do not exceed 0.03-0.04 units/minute except as salvage therapy when all other agents have failed 1, 2
  • Doses above 0.03-0.04 units/minute are associated with cardiac, digital, and splanchnic ischemia 2

Factors predicting better vasopressin response: higher norepinephrine infusion rate (≥0.30 mcg/kg/min), normal BMI, and lower lactate levels. 8 Obesity and hyperlactatemia are negatively associated with vasopressin responsiveness. 8

Third-Line Options

Add epinephrine (0.05-2 mcg/kg/min) when norepinephrine plus vasopressin fail to achieve target MAP. 1, 2

Add dobutamine (2.5-20 mcg/kg/min) for persistent hypoperfusion despite adequate MAP and vasopressor therapy, particularly when myocardial dysfunction is evident. 1, 2

  • Dobutamine addresses cardiac output rather than vascular tone 2
  • Titrate to endpoints reflecting tissue perfusion 1
  • Reduce or discontinue if worsening hypotension or arrhythmias develop 1

Adjunctive Therapy for Refractory Shock

Consider hydrocortisone 200 mg/day IV when hemodynamic stability cannot be restored with adequate fluid resuscitation and vasopressor therapy. 1, 2

Agents to Avoid

Do not use dopamine as first-line therapy—it is associated with 11% absolute increase in mortality and significantly more arrhythmias (53% increase in supraventricular arrhythmias, 65% increase in ventricular arrhythmias) compared to norepinephrine. 2, 4

  • Use dopamine only in highly selected patients with low risk of tachyarrhythmias or absolute/relative bradycardia 1, 4

Strongly avoid low-dose dopamine for renal protection (Grade 1A recommendation against). 1, 4

Do not use phenylephrine except in specific circumstances: norepinephrine causes serious arrhythmias, cardiac output is documented high with persistently low blood pressure, or as salvage therapy when all other agents have failed. 1, 2, 4

Critical Pitfalls to Avoid

  • Do not rely solely on blood pressure numbers—monitor tissue perfusion markers including lactate clearance, urine output, mental status, and capillary refill 2
  • Do not delay norepinephrine waiting to complete entire fluid resuscitation if life-threatening hypotension is present 2, 6
  • Do not use vasopressin as initial monotherapy—always add to norepinephrine 2, 4, 3
  • Do not escalate vasopressin beyond 0.03-0.04 units/minute routinely—add epinephrine instead 2
  • Recognize that norepinephrine doses >0.15 mg/min (approximately 0.25 mcg/kg/min in a 70kg patient) indicate severe shock requiring additional vasopressor agents 2, 8

Very High Dose Norepinephrine

In catecholamine-resistant septic shock, very high doses of norepinephrine (>4 mcg/kg/min) can be safe and effective, significantly increasing MAP and systemic vascular resistance while decreasing lactate concentrations, with a survival rate of 33.4% in otherwise extremely high mortality patients. 9 However, this represents salvage therapy for refractory shock after all other interventions have been optimized.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Vasopressor Management in Septic Shock

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Norepinefrina en el Manejo del Shock Séptico

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Early Use of Norepinephrine in Septic Shock Resuscitation (CENSER). A Randomized Trial.

American journal of respiratory and critical care medicine, 2019

Research

Early norepinephrine use in septic shock.

Journal of thoracic disease, 2020

Research

Refractory septic shock: efficacy and safety of very high doses of norepinephrine.

Methods and findings in experimental and clinical pharmacology, 2006

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.